FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4283662430> ?p ?o ?g. }

• W4283662430 endingPage "23288" @default.
• W4283662430 startingPage "23276" @default.
• W4283662430 abstract "A new versatile azide-bridged polymeric Cu(II) complex, namely, [Cu(L)(μ1,3-N3)]∞ (1), was synthesized utilizing an N,N,O-donor piperidine-based Schiff base ligand (E)-4-bromo-2-((2-(-1-yl)imino)methyl)phenol (HL), obtained via the condensation reaction of 1-(2-aminoethyl) piperidine and 5-bromo salicylaldehyde. The single-crystal X-ray diffraction analysis reveals that complex 1 consists of an end-to-end azido-bridged polymeric network, which is further rationalized with the help of a density functional theory (DFT) study. After routine characterization with a range of physicochemical studies, complex 1 is exploited to evaluate its biomedical potential. Initially, theoretical inspection with the help of a molecular docking study indicated the ability of complex 1 to effectively bind with macromolecules such as DNA and the human serum albumin (HSA) protein. The theoretical aspect was further verified by adopting several spectroscopic techniques. The electronic absorption spectroscopic analysis indicates a remarkable binding efficiency of Complex 1 with both DNA and HSA. The notable fluorescence intensity reduction of the ethidium bromide (EtBr)-DNA adduct, 4',6-diamidino-2-phenylindole (DAPI)-DNA adduct, and HSA after the gradual addition of complex 1 authenticates its promising binding potential with the macromolecules. The retention of the canonical B form of DNA and α form of HSA during the association of complex 1 was confirmed by implementing a circular dichroism spectral study. The association ability of complex 1 with macromolecules further inspired us to inspect its impact on different cell lines such as HeLa (cervical cancer cell), PA1 (ovarian cancer cell), and HEK (normal cell). The dose-dependent and time-dependent in vitro 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay suggests an effective antiproliferative property of complex 1 with low toxicity toward the normal cell line. Finally, the anticancer activity of complex 1 toward carcinoma cell lines was analyzed by nuclear and cellular staining techniques, unveiling the cell death mechanism." @default.
• W4283662430 created "2022-06-29" @default.
• W4283662430 creator A5015512542 @default.
• W4283662430 creator A5030227583 @default.
• W4283662430 creator A5057653613 @default.
• W4283662430 creator A5074962007 @default.
• W4283662430 creator A5081685793 @default.
• W4283662430 creator A5082139341 @default.
• W4283662430 creator A5085100883 @default.
• W4283662430 creator A5089014338 @default.
• W4283662430 date "2022-06-28" @default.
• W4283662430 modified "2023-10-09" @default.
• W4283662430 title "Response of Ancillary Azide Ligand in Designing a 1D Copper(II) Polymeric Complex along with the Introduction of High DNA- and HAS-Binding Efficacy, Leading to Impressive Anticancer Activity: A Compact Experimental and Theoretical Approach" @default.
• W4283662430 cites W1822112075 @default.
• W4283662430 cites W1869143477 @default.
• W4283662430 cites W1897202228 @default.
• W4283662430 cites W1984883623 @default.
• W4283662430 cites W1986499818 @default.
• W4283662430 cites W1991078204 @default.
• W4283662430 cites W1991353352 @default.
• W4283662430 cites W1991442403 @default.
• W4283662430 cites W1996320960 @default.
• W4283662430 cites W2008076873 @default.
• W4283662430 cites W2008445367 @default.
• W4283662430 cites W2012108057 @default.
• W4283662430 cites W2021018103 @default.
• W4283662430 cites W2023248146 @default.
• W4283662430 cites W2035836491 @default.
• W4283662430 cites W2037282195 @default.
• W4283662430 cites W2039559098 @default.
• W4283662430 cites W2040527477 @default.
• W4283662430 cites W2055775315 @default.
• W4283662430 cites W2057721426 @default.
• W4283662430 cites W2058598015 @default.
• W4283662430 cites W2059513289 @default.
• W4283662430 cites W2073131323 @default.
• W4283662430 cites W2074763492 @default.
• W4283662430 cites W2076940601 @default.
• W4283662430 cites W2077567454 @default.
• W4283662430 cites W2084517848 @default.
• W4283662430 cites W2085918372 @default.
• W4283662430 cites W2086681374 @default.
• W4283662430 cites W2089107879 @default.
• W4283662430 cites W2095084300 @default.
• W4283662430 cites W2105249240 @default.
• W4283662430 cites W2106824077 @default.
• W4283662430 cites W2111692492 @default.
• W4283662430 cites W2114918609 @default.
• W4283662430 cites W2121248338 @default.
• W4283662430 cites W2142604104 @default.
• W4283662430 cites W2143981217 @default.
• W4283662430 cites W2157567077 @default.
• W4283662430 cites W2158305374 @default.
• W4283662430 cites W2166689829 @default.
• W4283662430 cites W2168483951 @default.
• W4283662430 cites W2210834200 @default.
• W4283662430 cites W2229387995 @default.
• W4283662430 cites W2338357871 @default.
• W4283662430 cites W2491458126 @default.
• W4283662430 cites W2591580144 @default.
• W4283662430 cites W2766192711 @default.
• W4283662430 cites W2790784188 @default.
• W4283662430 cites W2795139701 @default.
• W4283662430 cites W2795590731 @default.
• W4283662430 cites W2810619199 @default.
• W4283662430 cites W2897208318 @default.
• W4283662430 cites W2917048769 @default.
• W4283662430 cites W2922508734 @default.
• W4283662430 cites W2965008467 @default.
• W4283662430 cites W2985345261 @default.
• W4283662430 cites W2989897241 @default.
• W4283662430 cites W3002047014 @default.
• W4283662430 cites W3031873577 @default.
• W4283662430 cites W3034878682 @default.
• W4283662430 cites W3038795570 @default.
• W4283662430 cites W3041644816 @default.
• W4283662430 cites W3090914345 @default.
• W4283662430 cites W3161053473 @default.
• W4283662430 cites W3173370559 @default.
• W4283662430 doi "https://doi.org/10.1021/acsomega.2c01403" @default.
• W4283662430 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35847281" @default.
• W4283662430 hasPublicationYear "2022" @default.
• W4283662430 type Work @default.
• W4283662430 citedByCount "2" @default.
• W4283662430 countsByYear W42836624302022 @default.
• W4283662430 countsByYear W42836624302023 @default.
• W4283662430 crossrefType "journal-article" @default.
• W4283662430 hasAuthorship W4283662430A5015512542 @default.
• W4283662430 hasAuthorship W4283662430A5030227583 @default.
• W4283662430 hasAuthorship W4283662430A5057653613 @default.
• W4283662430 hasAuthorship W4283662430A5074962007 @default.
• W4283662430 hasAuthorship W4283662430A5081685793 @default.
• W4283662430 hasAuthorship W4283662430A5082139341 @default.
• W4283662430 hasAuthorship W4283662430A5085100883 @default.
• W4283662430 hasAuthorship W4283662430A5089014338 @default.
• W4283662430 hasBestOaLocation W42836624301 @default.
• W4283662430 hasConcept C116569031 @default.
• W4283662430 hasConcept C137824038 @default.

• next